rabeprazole has been researched along with Colitis, Mucous in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A subset of patients with gastro-oesophageal reflux disease (GERD) does not achieve complete symptom resolution with proton pump inhibitor (PPI) therapy." | 1.35 | The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. ( Adlis, SA; Chey, WD; Nojkov, B; Rai, J; Rubenstein, JH; Saad, R; Shaw, MJ; Weinman, B, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nojkov, B | 1 |
| Rubenstein, JH | 1 |
| Adlis, SA | 1 |
| Shaw, MJ | 1 |
| Saad, R | 1 |
| Rai, J | 1 |
| Weinman, B | 1 |
| Chey, WD | 1 |
1 other study available for rabeprazole and Colitis, Mucous
| Article | Year |
|---|---|
The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Female; Gastroesophageal Reflux; H | 2008 |